Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo"
Nat Methods
.
2018 Apr;15(4):237.
doi: 10.1038/nmeth.4553.
Epub 2018 Mar 30.
Authors
Reynald M Lescarbeau
1
,
Bradley Murray
1
,
Thomas M Barnes
1
,
Nessan Bermingham
1
Affiliation
1
Intellia Therapeutics, Inc. Cambridge, Massachusetts, USA.
PMID:
29600988
DOI:
10.1038/nmeth.4553
No abstract available
Publication types
Comment
MeSH terms
CRISPR-Cas Systems*
Clustered Regularly Interspaced Short Palindromic Repeats*
Gene Editing
Mutation